Evonik clearly beats previous year’s results and aims for further growth
Evonik posted a strong increase in operating profit in 2024. Adjusted EBITDA rose 25 percent to €2.065 billion, within the guided range of €1.9 billion to 2.2 billion. ... MORE
Evonik posted a strong increase in operating profit in 2024. Adjusted EBITDA rose 25 percent to €2.065 billion, within the guided range of €1.9 billion to 2.2 billion. ... MORE
Evonik is putting in place a new segment structure and adopting a significantly leaner management model. ... MORE
In the third quarter, Evonik again earned significantly more than in the same period of the previous year. ... MORE
As a gateway to the world, the Antwerp (Belgium) site has played a major role in Evonik's global methionine business for 50 years ... MORE
Evonik significantly increased its earnings in the second quarter of 2024 despite a persistently difficult economic environment. ... MORE
In a difficult environment, Evonik has delivered another strong quarter, exceeding analysts' expectations. ... MORE